In glioblastoma, Ezrin interacts with and delocalizes the cytoskeletal-related protein neurofibromatosis type 2 (NF2), which carries out opposite activities in tumor growth (Morales et al., 2010). The gene discussed is NF2; the disease is glioblastoma.